The logo of Danish drugmaker Novo Nordisk in their ... weaker-than-expected data from a second late-stage trial of its obesity drug candidate CagriSema, knocking shares and stoking worries that ...

Body mass index (BMI) was almost three times more likely to classify children as overweight than waist circumference-to-height ratio, according to a new study.

As large retail chains dominate global food markets, unhealthy eating soars—highlighting an urgent need to reshape food environments to combat rising obesity rates. Study: Global food retail ...

Roche has entered an exclusive collaboration and licensing agreement with Danish obesity drug maker Zealand Pharma to ...

Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and ...

These results from the REPRIEVE (The Randomized Trial to Prevent Vascular Events in HIV) study were shared as the late breaking poster presentation, “Risk of Obesity, Cardiometabolic Disease and ...

Mar. 3, 2025 — Obesity rates are set to skyrocket, with one in six children and adolescents worldwide forecast to be obese by 2050, according to a new study. But with significant increases ...

BERLIN (Reuters) -Roche has entered an exclusive collaboration and licensing agreement with Danish obesity drug maker Zealand Pharma to co-develop petrelintide as an obesity therapy drug ...

Eli Lilly has said it is prepared to invest £279 million ($364 million) in the UK and work with the government to tackle serious public health challenges, including obesity. The proposal ...

Scotland has become the first country in the UK to back NHS use of Eli Lilly’s obesity therapy Mounjaro, clearing it to assist weight management in eligible patients. The Scottish Medicines ...

Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, ...

Human GWAS paradoxically linked FTO SNPs to both lean mass and sarcopenia/obesity. Here, Guang et al used CRISPR-edited stem cells to reveal that an obesogenic FTO SNP accelerates both muscle ...